20n Bio

Seed
20n.bio Biotech & Healthcare Philadelphia, United States
Total Funding $3.3M
Latest Round Undisclosed Seed
Last Announced May 20, 2026
Investors Undisclosed
Decision Makers 3 Verified

About 20n Bio

20n Bio is a VC-backed start-up dedicated to designing and screening cyclic peptides for therapeutics.

Company Details

Intelligence Dossier

Corporate & Operational Profile

Primary Industry Biotech & Healthcare
Funding Stage Seed
Global Headquarters Philadelphia, United States
Tracked Since Oct 2, 2026

Web & Domain Identity

Official Website 20n.bio
Domain Registered Date May 26, 2021

Social & Network Presence

X / Twitter Profile @20nBio (4 followers) Created on Feb 2022
LinkedIn Corporate Not linked

Company Milestones & Timeline

4 Events
  1. Capital Raise

    Seed announced

    startupintros.com

  2. Milestone

    X account created (@20nBio)

    4 followers

  3. Capital Raise

    Raised $3,300,000 · Seed

    startupintros.com

  4. Milestone

    Website domain registered

    20n.bio

Investors & Backers

Investor firms and individual backers were not publicly disclosed in available round filings for 20n Bio.

Funding History

2 Rounds
Seed · May 20, 2026
Seed · Dec 20, 2021

Founders & Leadership

1

Mingfu Zhu

Founder

Work email & phone locked Unlock →

Press Coverage & Sources

Recently Funded Biotech & Healthcare Startups

View all

Search the startup feeds free with 50 starter credits.

START FREE WITH 50 CREDITS
Recently funded startups
New SaaS launches
Never pay twice for contacts